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The profound impacts of childhood malnutrition, including both undernutrition and overweight, affect the economic, social and medical well-being of individuals, families, com-
munities and nations1,2. Undernutrition has been the most common 
form of malnutrition in LMICs3, but as populations experience 
economic growth, urbanization and demographic change, over-
weight is an emerging problem, leading to a double burden of mal-
nutrition (DBM). DBM may be manifested at the individual level 
as stunting in childhood followed by overweight in adulthood4. At 
the household level, research has focused on maternal and child 
indicators of malnutrition, whereas at the population level, preva-
lence of both undernutrition with overweight has been reported5. 
In children, DBM can be defined using different combinations of 
the various indicators of undernutrition (wasting and/or stunting) 
and overweight, obesity and diet-related noncommunicable dis-
eases (NCDs)6. While the most studied type of double burden is 
that of stunting and obesity, it is mostly applicable at the individual 
level among overweight adults who were previously stunted from 
chronic undernutrition during childhood. Wasting is associated 
with high rate of child mortality, whereas stunting has significant 
negative impact across the life course and is highly predictive of 
economic outcomes7. Public health nutrition programs designed to 
address undernutrition may exacerbate overweight8, thus a compre-
hensive understanding of DBM at the population level is crucial for 
the design of effective interventions.
Our aim was to determine the prevalence of overweight among 
children under 5 years old in LMICs (N = 105) for policy-relevant 
administrative units (district, state, and national level) and deter-
mine DBM by combining these estimates with those of wasting 
prevalence. As there is no broad consensus on the preferred interna-
tional child growth standards for assessing overweight and obesity 
among children under 5 (refs. 9,10), we used weight-for-height above 
established cutoff points defined by the World Health Organization 
(WHO). This was to analyze overweight estimates in relation to 
the Global Nutrition Targets (GNTs), which were developed based 
on WHO standards. Prevalence of early childhood overweight 
(including obesity) is defined as the proportion of children under 
5 with a weight-for-height z score (WHZ) more than two standard 
deviations (s.d.) above the WHO sex- and age-specific median 
growth reference standards10. This is different from the definition 
for children between the ages of 5–18 years, which is above one s.d. 
for overweight and above two s.d. for obese. We selected wasting as 
the comparative indicator against overweight, as both share recom-
mended population prevalence ranges, which can be used to create 
bivariate categories for DBM. Child wasting prevalence is defined as 
the proportion of children under 5 with a WHZ more than two s.d. 
below the median WHO growth standards10. Using WHZs allowed 
modeling of the three categories in the same distribution and thus 
enabled us to reliably determine the relative proportions for each 
category using an ordinal approach. Based on WHO and United 
Nations Children’s Fund (UNICEF)-defined thresholds, a moderate 
level of separate or dual conditions is defined as >5–10%, a high 
level as >10–15% and a very high level as >15% estimated preva-
lence11. Finally, we have defined DBM in this study as the simultane-
ous occurrence of >5% estimated prevalence for both wasting and 
overweight within the same locations in the same year.
Reversing the rise in childhood overweight is indicated in the 
United Nations (UN) Sustainable Development Goal 2.2 (ref. 12) and 
WHO’s GNTs to improve maternal, infant and young child nutri-
tion13. WHO has also set an international target to reduce wasting 
to <5% by 2025 (ref. 14). Quantifying changes in childhood over-
weight and wasting prevalence can be used to measure progress 
toward these targets, while identifying locales with simultaneous 
overweight and wasting will better inform intervention planning. 
In addition, mapping changes in DBM prevalence will provide a 
deeper understanding of the impact of past intervention strategies, 
including insight into overweight in children under 5.
Global and local variation in malnutrition trends
Globally in 2017, an estimated 38.3 million (5.6%) children under 5 
were overweight and 50.5 million (7.5%) were wasted15. The major-
ity (91%) of children under 5 affected by wasting and nearly half 
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(48%) of overweight children lived in LMICs, with Africa and Asia 
accounting for the largest shares of the global burden (25% and 46% 
of overweight and 27% and 69% of wasted children, respectively)16. 
Direct comparisons of population-level trends of childhood over-
weight and wasting generally provide regional- or country-level 
estimates5,16–20, potentially masking important subnational differ-
ences. Previously, we mapped 2000–2017 prevalence and trends in 
wasting, stunting and underweight among children under 5 across 
LMICs21 using Bayesian model-based geostatistical techniques22. 
Building from this approach and using data from 420 household 
surveys representing more than 3 million children, we mapped the 
relative burdens of overweight and wasting among children under 5 
in 105 LMICs from 2000 to 2017. Mapping with a continuous model 
allows us to incorporate geolocated data and covariates and produce 
gridded cell-level estimates that can be aggregated to intervention- 
or policy-relevant geographical areas as boundaries change over 
time. We present estimates at this local grid cell-level and aggregate 
to first administrative (such as states and provinces), second admin-
istrative (such as districts and departments) and national levels. 
On the basis of 2000 to 2017 weighted annualized rates of change 
(AROC), which apply more weight to recent data, we predict preva-
lence of overweight and wasting and estimate their double burden 
in 2025. The full array of outputs are available at the Global Health 
Data Exchange (http://ghdx.healthdata.org/record/ihme-data/lmic-
double-burden-of-malnutrition-geospatial-estimates-2000-2017) 
and can be further explored with our customized visualization tools 
(https://vizhub.healthdata.org/lbd/dbm).
Prevalence and trends in early childhood overweight
Across LMICs, the prevalence of early childhood overweight 
increased from 5.2% (95% uncertainty interval, 4.5–5.4%) to 
6.0% (4.8–6.1%) in the modeled study period. Between 2000 and 
2017, there were noticeable differences in estimated levels by area 
(Fig. 1a,b). Although levels varied broadly across LMICs, every 
modeling region had areas with high estimated prevalence in 2017 
(Fig. 1b and Extended Data Fig. 1). These included large contiguous 
areas across most Central American, Caribbean and South American 
countries and areas with ≥15% estimated prevalence in central 
Cuba, southern Panama, western Paraguay, scattered throughout 
several eastern Brazilian states (for example, in Rio Grande do Sul, 
Minas Gerais, Santa Catarina, Paraná and São Paulo) and Peru’s 
coastal cities of Tacna, Ilo, Islay, Callao, Trujillo and Lima. In Africa, 
most countries bordering the Sahel had low overweight prevalence 
(0–5%); areas with >15% estimated prevalence were concentrated 
in North Africa throughout Morocco, Algeria, Tunisia, Egypt and 
select areas of Libya, as well as along South Africa’s southern coast 
and in pockets in Botswana and Zambia. Large areas in eastern 
and northern China and throughout Mongolia had an estimated 
overweight prevalence >15%. Countries in the Oceania region 
had moderate to high levels, with estimates over 15%, such as in 
Indonesia’s Jakarta Pusat and Jakarta Barat regencies (in Jakarta 
Raya; 17.7% (15.3–18.4%)). The North Africa, Central Asia and 
Southeast Asia regions showed vast differences across nations; for 
example, Afghanistan, Sudan and Laos had <5% estimated national 
prevalence, whereas Egypt, Uzbekistan, Morocco, Kyrgyzstan and 
Thailand had ≥15%. South Asia’s estimated levels ranged from <5% 
in Bangladesh to ≥10% Bhutan. Estimated prevalence in Karbala 
city in Karbala, Iraq, increased from 13.6% (12.4–14.1%) in 2000 to 
29.3% (22.9–29.1%) in 2017. Thailand’s southern areas experienced 
large increases in estimated prevalence levels; Sathorn district, 
Bangkok Metropolis, had 24.1% (20.1–24.8%) overweight in 2000 
and 33.9% (27.5–35.5%) in 2017. Areas with the greatest decrease 
included Churcampa district, Huancavelica, Peru, decreasing 
from 17.5% (17.4–17.6%) in 2000 to 10.3% (10.2–10.4%) in 2017. 
Similarly, overweight in Al Gash district, Kassala, Sudan, declined 
from 14.1% (13.6–14.5%) to 6.1% (5.2–6.2%).
Within-country differences in estimated overweight levels were 
found in 37 (35.2%) LMICs, including South Africa, Peru and 
Indonesia, which had twofold differences in estimated prevalence 
across second administrative units in 2017. South Africa had high 
estimated national levels (24.9% (23.9–25.2%)); however, the prov-
ince of Northern Cape had moderate levels (14.6% (13.6–14.9%)), 
whereas the southeastern province of Eastern Cape had very high 
levels (32.7% (30.8–33.9%)). Disparities were further pronounced at 
the district level. Siyanda (Northern Cape) had 12.5% (11.6–12.9%) 
prevalence, whereas Ugu (KwaZulu-Natal) had 36.7% (34.0–38.2%). 
Nearly every modeling region had areas with overweight preva-
lence that ranked among the highest decile in 2000, 2017 or both 
years (Fig. 1c).
Overall, the number of overweight children under 5 in LMICs 
also showed a significant increase from 30.0 million (22.8–38.5) to 
55.5 million (44.8–67.9) in the study period (Fig. 2a,b). By 2017, 
26.2 million (24.1–27.2 million; 36.0%) of those affected lived in 
eastern Asia, northern Africa or South America. An estimated 
8.6% (8.5–9.9%) of first administrative units had fewer than 1,000 
overweight children under 5, 47.5% (47.2–49.5%) had 1,000 to 
<10,000, 43.8% (40.6–44.3%) had 10,000 to <100,000 and just 3.8% 
(3.7–3.9%) had 100,000 or more. Some areas, such as northern 
and central parts of Bolivia, experienced large annualized declines 
such that their ranking among the highest estimated prevalence 
decile in 2000 no longer applied in 2017. In contrast, a large area in 
India, south of the Tropic of Cancer, experienced large annualized 
increases in overweight; its ranking among the lowest prevalence 
decile in 2000 was not maintained in 2017. All modeled regions 
had areas that experienced average annualized increases of ≥1% in 
overweight prevalence (Fig. 2c). Unless current trajectories change, 
prevalence of overweight will continue to increase to 2025 (Fig. 2d).
Prevalence and trends in child wasting
The estimated prevalence of early childhood wasting decreased over-
all across LMICs between 2000–2017, from 8.4% (7.9–9.9%) to 6.4% 
(4.9–7.9%). The most notable relative reductions were seen across 
North Africa and in select countries in sub-Saharan African (SSA) 
regions, Central and Andean America and Southeast Asia regions. 
In Burkina Faso’s Ganzourgou district, estimated levels declined 
from 20.2% (19.1–21.3%) in 2000 to 11.6% (10.9–12.1%) in 2017, 
in Yemen’s Ash Shaikh Outhman district from 25.1% (22.2–26.3%) 
to 21.3% (18.9–22.2%) and in Sudan’s Al Mahagil district from 
31.9% (31.4–32.6%) to 12.2% (10.5–12.9%). Increases in estimated 
prevalence also occurred, such as in Pakistan’s Makran district 
(Baluchistan), from 7.4% (6.7–7.6%) to 11.4% (10.4–11.8%).
In 2017, there were several instances of contrasting geographic 
patterns of child wasting compared to those of overweight. Many 
Central American, Caribbean and South American countries (46%; 
11 of 24) affected by overweight (>15% prevalence) met the WHO 
GNTs for <5% prevalence of wasting across all districts based on 
estimated prevalence (Fig. 3a,b and Extended Data Fig. 2). Estimated 
wasting prevalence was ≥15% in 31.9% (850 of 2,661) and ≥20% in 
12.9% (342) of second administrative units across Central and South 
Asian countries, contributing to high prevalence at the national 
level in India (15.7% (15.4–15.9%)), Pakistan (12.2% (11.8–12.4%)) 
and Sri Lanka (11.2% (10.5–11.5%)); Afghanistan and Bangladesh 
maintained high levels (estimated prevalence ≥10%) across many 
areas. Local-level estimates delineate very high wasting prevalence 
(≥15%) along the African Sahel from Mauritania to Sudan, in the 
northeastern Horn of Africa and neighboring countries of Eritrea, 
Ethiopia, Somalia, Kenya, South Sudan and Yemen, in select areas 
in Algeria and Egypt, and across Madagascar. In the Middle East, 
Syria exceeded 15% estimated prevalence throughout most areas 
and Iraq’s southeastern districts exceeded 10%. Estimated levels 
of wasting were relatively uniform and low across East Asia, with 
the exception of a few focal areas exceeding 10% or 20% in central 
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pockets of east China. Most areas in Southeast Asia and Oceania 
experienced moderate-to-high estimated wasting levels (~10%), 
whereas some areas in Indonesia’s southern-most islands in Nusa 
Tenggara (Timur state) exceeded 15% prevalence. Meanwhile, some 
areas in Myanmar, Thailand, northern Laos and Vietnam had very 
low levels, approaching the WHO GNTs.
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Fig. 1 | Prevalence of overweight children under 5 in LMiCs (2000–2017). a,b, Prevalence of overweight among children under 5 at 5 × 5-km resolution  
in 2000 (a) and 2017 (b). c, Overlapping population-weighted lowest and highest 10% of grid cells and AROC in overweight from 2000 to 2017.  
d, Overlapping population-weighted quartiles of overweight and relative 95% uncertainty in 2017. Maps reflect administrative boundaries, land cover,  
lakes and population; gray colored areas have grid cells classified as ‘barren or sparsely vegetated’ and had fewer than ten people per 1 × 1-km grid cell  
in 2017 or were not included in this analysis39–45. Maps were generated using ArcGIS Desktop 10.6.
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Between 2000 and 2017, the number of children under 5 
affected by wasting decreased from 62.3 (55.1–70.8) million to 58.3 
(47.6–70.7) million, 28.4% (28.2–28.5) of whom were in Africa 
and 65.4% (63.6–67.3) in South Asia in 2017 (Fig. 3c,d). Despite 
maintaining high estimated prevalence in many areas, all regions 
in Africa had areas that experienced among the highest rates of 
annualized declines in 2000–2017; only a few areas in Chad, Sudan, 
South Sudan, Ethiopia and Kenya were among the highest decile 
of estimated prevalence levels in both 2000 and 2017 (Fig. 4a,b). 
Progress differed across and within African countries, with some 
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Fig. 2 | Number of overweight children under 5 in LMiCs (2000–2017) and progress toward 2025. a,b, Number of children under 5 affected by 
overweight at a 5 × 5-km resolution (a) and by first administrative units (b). c, Annualized decrease (AD) in overweight prevalence from 2000 to 2017.  
d, Grid cell-level predicted overweight prevalence in 2025 based on AD achieved from 2000 to 2017 and projected from 2017. Maps reflect administrative 
boundaries, land cover, lakes and population; gray colored areas have grid cells classified as ‘barren or sparsely vegetated’ and had fewer than ten people 
per 1 × 1-km grid cell in 2017 or were not included in this analysis39–45. Maps were generated using ArcGIS Desktop 10.6.
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nations, such as Nigeria, Ethiopia and Namibia, experiencing both 
annualized decreases and increases in wasting within their borders 
(Fig. 4c). Overall, South America and South SSA demonstrated 
the largest annualized declines (≥5%) across most of their areas 
and regions of Latin America and the Caribbean, the Middle 
East, South Asia, Southeast Asia and Oceania experienced mostly 
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Fig. 3 | Prevalence of wasted children under 5 in LMiCs (2000–2017). a–c, Prevalence of moderate and severe wasting among children under 5 at a 
5 × 5-km resolution in 2000 (a) and 2017 (b). c, Overlapping population-weighted lowest and highest 10% of grid cells and AROC in wasting from 2000 
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2017 or were not included in this analysis39–45. Maps were generated using ArcGIS Desktop 10.6.
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annualized increases. Large areas of India and parts of central 
Pakistan experienced some of the highest prevalence levels through-
out the study period, as well as annualized increases. Nearly all 
South Asian countries had large contiguous areas of stagnation or 
annualized increases in wasting; given recent rates of progress, few 
will meet the WHO GNTs in all their locations by 2025 (Fig. 4d). By 
2025, 68 (64.8%) of LMICs are predicted to fail to meet the <5% tar-
get nationally, all of which are in Africa, Asia and the Middle East. 
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Fig. 4 | Number of wasted children under 5 in LMiCs (2000–2017) and progress toward 2025. a,b, Number of children under 5 affected by wasting 
at the 5 × 5-km resolution (a) and by first administrative units (b). c, AD in wasting prevalence from 2000 to 2017. d, Grid cell-level predicted stunting 
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Based on subnational estimates, 88 (83.8%) and 94 (89.5%) will fail 
to meet the wasting WHO GNTs in all first and second administra-
tive units, respectively.
Double burden of wasting and overweight
Nearly every modeling region had subnational areas with at least 
moderate co-occurrence of wasting and overweight (≥5% estimated 
prevalence of both conditions) in 2017 (Fig. 5 and Extended Data 
Fig. 3). Exceptions were Central and South America, where Guyana 
was the only example of moderate DBM (5%–10% of both condi-
tions). In Africa, much of the Democratic Republic of the Congo, 
Cameroon, Republic of Congo, Zambia and southern Botswana 
demonstrated high DBM (≥10% of both overweight and wasting). 
Areas in central Morocco reached some of the highest levels of 
DBM (≥15% overweight, 10–15% wasting), whereas much of the 
rest of North Africa had high estimated overweight (10–15%) and 
moderate estimated wasting (5–10%). Locations scattered through-
out Iraq, India and in Southeast Asia mostly experienced moder-
ate wasting (such as Myanmar at 5–10%) or moderate DBM (such 
as Indonesia at 5–10%), reaching moderate-to-high DBM levels in 
select areas (such as central Papua New Guinea and Cambodia at 
5–10% overweight, 10–15% wasting; Thailand, 10–15% overweight, 
5–10% wasting). Relatively rare in East Asia, DBM was at moder-
ate levels at most (5–10% both conditions), such as in provinces in 
southeastern China. At the national level, 25.7% (27 of 105) LMICs 
were moderately affected and 5.7% (6 of 105) were highly affected 
by both overweight and wasting (≥5% and ≥10% prevalence of 
both conditions, respectively). Subnationally, however, 70.5% (74 of 
105) of LMICs had moderately affected districts, 11.4% (12 of 105) 
had highly affected districts and 2.9% (3 of 105) had districts with 
very high DBM (≥5%, ≥10% and ≥15% prevalence of both condi-
tions, respectively).
Although childhood nutritional status generally improved 
over 2000–2017, subnational variation in childhood overweight, 
wasting and DBM was apparent. Declines in wasting and over-
weight prevalence in South Africa’s western areas led to a decrease 
in DBM prevalence, from high levels in Siyanda district in 2005 
(10–15% estimated wasting and overweight) to moderate levels 
in 2017 (5–10% both conditions); overweight remains very high, 
however, on the southern coast (≥15%). On the basis of annu-
alized trends, 25.7% (27 of 105) of LMICs are predicted to have 
districts with at least moderate DBM by 2025 and 34.3% (36 of 
105) are predicted to have high DBM districts (Fig. 5). Between 
2000 and 2017, 8.6% (9 of 105) of LMICs had first administrative 
units that experienced transition from high estimated prevalence 
of wasting (≥10%) to normal weight (<5% both wasting and over-
weight). Nearly one-third, 32.3% (34 of 105) of LMICs had first 
administrative units that transitioned from normal weight to high 
overweight and 7.6% (8 of 105) transitioned from high wasting to 
high DBM.
Discussion
This study provides overweight estimates and combines them with 
wasting estimates to highlight DBM across LMICs at a fine geospa-
tial scale. This enables efficient targeting of local-level interventions 
to improve nutrition outcomes in vulnerable populations. The fig-
ures presented here, as well as our online visualization tools, allow 
for comparing overweight and wasting levels and trends across and 
within countries for each year from 2000 to 2017, leveraging the 
spatially resolved underlying data and covariates to produce detailed 
spatial estimates across all modeled regions. Our estimates show the 
global trend in early childhood wasting is declining, but areas with 
high prevalence and little progress, such as in the Sahel and South 
Asia, remain. Meanwhile, childhood overweight prevalence has 
increased, especially in tropical South America and regions in the 
Middle East, Central Asia and Africa.
Across LMICs, trends in childhood overweight have increased 
while wasting decreased by different magnitudes from 2000–2017, 
leading to the emergence of DBM in several areas. As countries 
experience economic growth, they may undergo nutritional transi-
tions wherein the challenges of undernutrition are replaced by those 
of overweight or the co-occurrence of both conditions4. Overall, 
food security has improved across LMICs in the past decade, which 
has led to increased availability of calories at the population level23. 
Although overweight is a reflection of excess calorie intake and 
reduced energy expenditure, there is a growing recognition that at 
the root of the rising rates of overweight are complex interactions 
between societal, environmental, food industry and individual fac-
tors, including biological, psychological and economical factors24. 
Understanding the factors underpinning these trends is key to pre-
dicting how nutrition programs can accelerate amelioration of wast-
ing without incurring high rates of childhood overweight.
Although we included urbanicity as a covariate in our models, 
we were unable to reliably stratify our results by urban and rural 
areas. Urbanization is widely viewed as a key driver of the rise in 
overweight, but an increase in rural body mass index has recently 
been recognized as a main driver of the global epidemic of obe-
sity in adults25. Such an analysis would thus add important context 
to our estimates. Case studies in China, Egypt, India, Mexico, the 
Philippines and South Africa have demonstrated a consistent trend 
of increased energy content of diets26. Relatively rural areas in China 
have experienced an increase in the intake of animal source foods 
and edible oils, likely due to the decreasing cost of these products. 
Further, increased use of motor vehicles and labor-saving technolo-
gies in agriculture have caused a decrease in energy expenditure 
in all these countries. In Brazil, household consumption of high-
calorie ultra-processed foods has steadily replaced that of fresh or 
minimally processed foods27. Nutritious diets consisting of the latter 
can help prevent both wasting and stunting, thus work is needed 
to identify how dietary patterns differ between wasted and over-
weight children and the underlying factors causing those differ-
ences. Widespread collection and assembly of nutrition data from 
older children and adults would also contribute to a more complete 
understanding of longitudinal nutrition patterns.
In addition to tracking progress, child nutrition measurements 
are important for predicting and averting morbidity and mortal-
ity. Wasting is often indicative of short-term weight loss due to 
food shortages, famine or diseases such as diarrhea28–30 and puts 
children at greater risk of succumbing to common infections28. 
Childhood overweight is likely to progress into adulthood and is 
associated with NCDs24, including cardiovascular disease, type 
2 diabetes, sleep apnea and cancer31,32. Routine monitoring and 
reporting of child nutrition status can highlight trends and act as 
an early warning for health systems, particularly in the context of 
epidemiological transitions4.
Although overall spending on development assistance and 
investments to address malnutrition from government donors have 
remained steady, those from multilateral institutions have increased 
since 2013, amounting to US$856 million in overseas development 
assistance in 2016 (ref. 15). These investments, however, fall short 
of the estimated US$3.5 trillion per year that malnutrition costs 
society, US$500 billion of which is attributable to overweight and 
obesity33. By focusing on prevention and early action, healthcare 
costs can be reduced and human capital increased. One difficulty, 
however, is addressing the different forms of malnutrition in tan-
dem. Multiple forms of malnutrition are the new normal, accord-
ing to the GNR15 and Scaling Up Nutrition34,35. Double-duty actions 
that could simultaneously combat undernutrition, overweight, 
obesity, and diet-related NCDs have been proposed to address this 
problem36–38. Despite progress in identifying such actions, such as 
the promotion of breastfeeding, double-duty approaches have not 
been widely adopted. To better respond to the diverse and rapidly 
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evolving nutrition challenges facing LMICs, sustainable and health-
promoting food systems are needed to slow the development of 
DBM. Due to the multiple causality of malnutrition, multisector 
collaboration is required, including agriculture, trade and industry, 
environment, communication and education, all working towards 
policy and intervention coherence8,24.
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Fig. 5 | Overlapping population-weighted quartiles of overweight and wasting prevalence in children under 5 across LMiCs in 2017 and 2025.  
a–d, Prevalence of moderate-to-severe overweight (OVR) and wasting (MSW) among children under 5 years of age in 2017 at the first administrative 
unit (a) and at a 5 × 5-km resolution (b). c,d, Estimated prevalence of moderate to severe OVR and MSW among children under 5 years of age in 2025 at 
the first administrative unit (c) and at a 5 × 5-km resolution (d). Quartile cutoffs were 0–5%, ≥5–10%, ≥10–15% and ≥15%. Maps reflect administrative 
boundaries, land cover, lakes and population; gray colored areas have grid cells classified as ‘barren or sparsely vegetated’ and had fewer than ten people 
per 1 × 1-km grid cell in 2017 or were not included in these analyses39–45. Maps were generated using ArcGIS Desktop 10.6.
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There are several limitations to these analyses, mainly concern-
ing the quantity and quality of the underlying data in the models, 
as shown in our uncertainty maps (Figs. 1f and 2f). Missing or 
improbable values in the primary data may contribute bias in the 
estimates and thus we have incorporated covariates to improve the 
estimates in areas where data are sparse. Additionally, differences in 
measurement techniques between surveys, scale miscalibration or 
equipment failure and poor training and standardization of mea-
surers may contribute bias. Although our estimates were produced 
at a high spatial resolution, they were limited to prevalence by area, 
rather than the co-occurrence of wasting and overweight experi-
enced by the same households or individuals. Additional work is 
required to identify the immediate and basic causes that lead to 
both wasting and obesity coexisting in the same geographical areas 
so that appropriate solutions can be identified. Future studies will 
consider maternal indicators associated with child nutritional out-
comes, such as anemia and examine the co-distribution of over-
weight and stunting to broaden our assessment. New modeling 
approaches are currently in development to provide full distribu-
tions of height, weight and age, for more complete assessments of 
DBM using all important indicators of undernutrition.
Commendable gains have been made globally against child 
malnutrition over the past two decades. Our mapped estimates, 
however, show that high rates of wasting persist and overweight is 
increasing among young children in many LMICs. Identifying the 
causes underlying the presence of wasting or overweight in children 
living in the same community is necessary to formulate appropriate 
solutions. The estimates provided by this study can aid in the iden-
tification of specific areas where further insight can be gathered and 
trials of policy interventions administered, ultimately contributing 
to the UN Decade of Action on Nutrition process of sustained and 
coherent implementation of policies and programs37.
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Methods
Overview. Our study follows the Guidelines for Accurate and Transparent Health 
Estimates Reporting48 (Supplementary Table 1). The analyses used model-based 
geostatistics to generate local-, administrative- and national-level estimates of 
children under 5 overweight, wasting prevalence and double burden in LMICs 
over time. Using an ensemble modeling framework that fed into a Bayesian 
generalized linear mixed-effects model with a correlated space–time random 
effect and 1,000 draws from an approximate posterior distribution, we generated 
annual prevalence estimates for overweight and wasting on a 5 × 5-km grid over 
105 LMICs from 2000 to 2017 and aggregated these to administrative and national 
levels (Supplementary Table 2). Countries were selected for inclusion in this study 
using the socio-demographic index (SDI), a summary measure of development 
that combines education, fertility and poverty47. Selected countries were in the low, 
lower-middle and middle SDI quintiles, with several exceptions (Supplementary 
Table 2). China, Libya, Malaysia, Panama and Turkmenistan were included despite 
higher-middle SDIs for geographic continuity with other included countries. 
Albania, Bosnia-Herzegovina and Moldova were excluded due to geographic 
discontinuity and lack of available survey data. We did not conduct estimates 
for the island nations of American Samoa, Federated States of Micronesia, Fiji, 
Kiribati, Marshall Islands, Samoa, Solomon Islands or Tonga, as no survey data 
could be sourced.
Data. Surveys and child anthropometry data. We extracted individual-level height, 
weight and age data for children under 5 from household survey series including 
the Demographic and Health Surveys, Multiple Indicator Cluster Surveys, Living 
Standards Measurement Study and Core Welfare Indicators Questionnaire, among 
other country-specific child health and nutrition surveys49–52 (Supplementary 
Tables 3 and 4). Included in our models were 420 georeferenced household 
surveys representing over 3 million children under 5. Each individual child record 
was associated with a cluster, a group of neighboring households or a ‘village’ 
that acted as a primary sampling unit. Approximately 185 surveys with height, 
weight and age data included geographic coordinates or precise place names 
for each cluster within that survey. In the absence of geographic coordinates for 
each cluster, we assigned data to the smallest available administrative areal unit 
in the survey (polygon) while accounting for the survey sample design (15,781 
survey polygons for overweight and wasting)53,54. Boundary information for these 
administrative units was obtained as shapefiles either directly from the surveys or 
by matching to shapefiles in the Global Administrative Unit Layers55 database or 
the Database of Global Administrative Areas56. In select cases, shapefiles provided 
by the survey administrator were used or custom shapefiles were created based on 
survey documentation. These areal data were resampled to point locations using 
a population-weighted sampling approach over the relevant areal unit with the 
number of locations set proportionally to the number of grid cells in the area and 
the total weights of all the resampled points summing to one43.
Select data sources were excluded for the following reasons: missing survey 
weights for areal data, missing sex or age variable, incomplete sampling (for 
example, only children ages 0–3 years measured) or untrustworthy data (as 
determined by the survey administrator or by inspection). Details on the survey 
data excluded for each country can be found in Supplementary Table 5. Data 
extraction and processing methods have been described previously21.
Child anthropometry. Using height, weight, age and sex data for each individual, 
WHZs were calculated using the age-, sex- and indicator-specific lambda-mu-
sigma values from the 2006 WHO Child Growth Standards10,57. The lambda-mu-
sigma methodology allows for Gaussian z score calculations and comparisons 
to be applied to skewed, non-Gaussian distributions58. A child was classified as 
overweight or wasted if their weight-for-height/length was more than two s.d. 
(z scores) above or below the WHO growth reference population, respectively59. 
These individual-level data observations were then collapsed to cluster-level totals 
for the number of children sampled and total number of children under 5 affected 
by overweight and the total number of children who are wasted out of the children 
who were not overweight.
Temporal resolution. We estimated prevalence of overweight and wasting annually 
from 2000 to 2017 using a model that allowed us to account for data points 
measured across survey years, and as such, allows us to predict at monthly or finer 
temporal resolutions. We were limited, however, both computationally and by the 
temporal resolution of covariates (Supplementary Table 6) and thus produced only 
annual estimates.
Seasonality adjustment. WHZs were used to calculate individual child wasting 
status. As a data preprocessing step, we performed a seasonality adjustment on 
individual-level child weights in order to account for differences in observed child 
weight that may have been due to food scarcity during the month in which the 
survey was conducted. To adjust weight measurements, we fitted a model for each 
region with a 12-month seasonal spline, a country-level fixed effect and a smooth 
spline over the duration of our data collection using the mgcv package in R and the 
following formula:
WHZ  scc monthð Þ þ stp tð Þ þ as:factor countryð Þ:
I
Month is the integer-valued month of the year (1, …, 12), t is the time of 
the interview in integer months since the earliest observation of any child in 
the dataset and country is a factor variable representing the country where the 
observation was recorded. We modeled the periodic component on months using 
12 cyclic cubic (cc) regression splines basis functions and we accounted for a 
smooth longer time temporal trend using four thin-plate (tp) splines. The country 
effects and the long-term temporal spline were included only to avoid confounding 
during fitting of the seasonal spline fit and neither country effects nor the long-
term trend was used in the seasonal adjustment. We then adjusted all observations 
to account for the difference in the seasonal period between the month of the 
interview and an average day of the year as determined by which days aligned with 
the mean of the periodic spline.
Spatial covariates. In order to leverage strength from locations with observations  
to the entire spatial–temporal domain, we compiled several 5 × 5-km raster  
layers of putative socioeconomic and environmental correlates of malnutrition in 
the 105 LMICs (Supplementary Table 6). These covariates were selected based on 
their potential to be predictive for overweight and wasting, according to literature 
review and plausible hypothesis as to their influence. Acquisition of temporally 
dynamic datasets, where possible, was prioritized to best match our observations 
and thus predict the changing dynamics of the two indicators. Of the 12 covariates 
included, 6 were temporally dynamic and were reformatted as a synoptic mean 
over each estimation period or as a mid-period year estimate. These included 
average daily mean rainfall (precipitation), educational attainment in women of 
reproductive age (15–49 years old), enhanced vegetation index, fertility, urbanicity 
and population. The remaining six covariate layers were static throughout the 
study period and were applied uniformly across all modeling years; these covariates 
included growing season length, irrigation, nutritional yield for vitamin A, 
nutritional yield for protein, nutritional yield for iron and travel time to nearest 
settlement >50,000 inhabitants.
To select covariates and capture possible nonlinear effects and complex 
interactions between them, an ensemble covariate modeling method was 
implemented60. For each region, three submodels were fitted to our dataset, using 
all of our covariate data as explanatory predictors: generalized additive models, 
boosted regression trees and lasso regression. Each submodel was fitted using 
fivefold cross-validation to avoid overfitting and the out-of-sample predictions 
from across the five holdouts were compiled into a single comprehensive set of 
out-of-sample predictions from that model. Additionally, the same submodels 
were also run using 100% of the data and a full set of in-sample predictions were 
created. The three sets of out-of-sample submodel predictions were fed into the 
full geostatistical model as the explanatory covariates when performing the model 
fitting. The in-sample predictions from the submodels were used as covariates 
when generating predictions using the fitted full geostatistical model. A recent 
study has shown that this ensemble approach can improve predictive validity by up 
to 25% over an individual model60.
Analysis. Geostatistical model. In this study, wasting was defined as the proportion 
of children under 5 below negative 2 WHZ (<−2 WHZ); normal category, the 
proportion of children under 5 between negative 2 and positive 2 WHZ z score 
(>−2 and <2 WHZ); and overweight was defined as the proportion of children 
under 5 above positive 2 WHZ z score (>2 WHZ) as defined in the WHO growth 
reference population59. To model the full distribution of possible indicators of 
nutritional status in WHZ (wasting (<−2 WHZ), normal (>−2 and <2 WHZ) and 
overweight (>2 WHZ)), we used an ordinal modeling approach61,62 to estimate the 
relative proportion of each indicator. A similar modeling approach was used to 
estimate vaccine coverage in Africa63.
We used a continuation ratio model to estimate the prevalence of three 
categories: wasting, normal weight and overweight. We first modeled the 
proportion of wasting children within a Bayesian hierarchical framework using 
logistic regression with a spatially and temporally explicit generalized linear 
mixed-effects model. Second, we modeled the proportion of the children that were 
overweight conditioned on not being wasted using the same Bayesian modeling 
framework. The estimates from the second conditional model were then combined 
with the wasting estimates to compute the proportion of overweight children in the 
full distribution.
At each cluster, j, where j = 1, 2, …n, and time t, where t = 2000, 2001, …2017, the 
prevalence of wasting was modeled using the observed number of children in cluster 
d, who were found to be wasted as a binomial count data Cd among a sample size Nd.
Cd jpi dð Þ;t dð Þ;Nd  Binomial pi dð Þ;t dð Þ;Nd
� 8 observe clusters d logit pi;t� 
¼ β0 þ Xi;tβþ Zi;t þ ϵctrðiÞ þ ϵi;t þ Zi;t8i 2 spatial domain 8 t 2 time domainP3
h¼1
βh ¼ 1
ϵctr  iid Normal 0; γ2ð Þ
ϵi;t  iidNormal 0; σ2ð Þ
Z  GPð0;Σspace  ΣtimeÞ
Σspace ¼ ω2Γ νð Þ2v�1 ´ κDð Þν ´Kν κDð Þ
Σtimej;k ¼ ρjk�jj
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For indices d, i and t, *(index) is the value of * at the index. The annual 
prevalence of wasting, pi,t, in cluster i, in time t, was modeled as a linear 
combination of the three submodels, (generalized additive models, boosted 
regression trees and lasso regression), rasterized covariate values, Xi,t, a correlated 
spatiotemporal random effect term Zi,t, country random effects ϵctrðiÞ
I
, with one 
unstructured country random effect fitted for each country in the modeling 
region and all ϵctr
I
 sharing a common variance parameter, γ2, and an independent 
nugget random effect ϵi;t
I
, with variance parameter, σ2. Coefficients βh in the 
three submodels h = 1, 2, 3 represent their respective predictive weighting in 
the logit link, while the joint error term Zi,t accounts for residual spatiotemporal 
autocorrelation between individual data points that remain after accounting for 
the predictive effect of the submodel covariates, the country-level random effect 
ϵctrðiÞ
I
 and the nugget, ϵi;t
I
. The residuals Zi,t, were modeled as a three-dimensional 
Gaussian process in space–time centered at zero and with a covariance matrix 
constructed from a Kronecker product of spatial and temporal covariance kernels. 
The spatial covariance, Σspace, was modeled using an isotropic and stationary 
Matérn function64 and temporal covariance, Σtime, as an annual autoregressive 
(AR1) function over the 18 years represented in the model. In the stationary 
Matérn function, Γ is the gamma function, Kv is the modified Bessel function of 
order v > 0, κ > 0 is a scaling parameter, D denotes the Euclidean distance and ω2 is 
the marginal variance. The scaling parameter, κ, is defined to be κ ¼ ffiffiffiffiffi8vp =δ
I
,  
where δ is a range parameter (about the distance where the covariance function 
approaches 0.1) and v is a scaling constant, which is set to 2 rather than fitted from 
the data. The number of rows and the number of columns of the spatial Matérn 
covariance matrix are both equal to the number of spatial mesh points for a given 
modeling region. The number of rows and the number of columns of the spatial 
Matérn covariance matrix are both equal to the number of spatial mesh points for 
a given modeling region. In the AR1 function, ρ is the autocorrelation function 
and k and j are points in the time series where |k−j| defines the lag. The number 
of rows and the number of columns of the AR1 covariance matrix are both equal 
to the number of temporal mesh points (18). The number of rows and the number 
of columns of the space–time covariance matrix, Σspace⊗Σtime, for a given modeling 
region are both equal to the number of spatial mesh points × the number of 
temporal mesh points.
This approach leverages the residual correlation structure to more 
accurately predict prevalence estimates for locations with no data, while also 
propagating the dependence in the data through to uncertainty estimates65. The 
posterior distributions were fitted using computationally efficient and accurate 
approximations in R-INLA66,67 (integrated nested Laplace approximation) with the 
stochastic partial differential equations68 approximation to the Gaussian process 
residuals using R project v.3.5.1. The stochastic partial differential equations 
approach using INLA has been demonstrated elsewhere, including the estimation 
of health indicators, particulate air matter and population age structure69–71. 
Uncertainty intervals were generated from 1,000 draws (statistically plausible 
candidate maps)72 created from the posterior-estimated distributions of  
modeled parameters.
Post estimation. To transform grid cell-level estimates into a range of information 
useful to a wide constituency of potential users, estimates were aggregated at 
first and second administrative units specific to each country and at national 
levels73. Although the models can predict all locations covered by available raster 
covariates, all final model outputs for which land cover was classified as ‘barren or 
sparsely vegetated’ on the basis of Moderate Resolution Imaging Spectroradiometer 
(MODIS) satellite data (2013) were masked74. Areas where the total population 
density was less than ten individuals per 1 × 1-km grid cell in 2015 were also 
masked in the final outputs.
Model validation. Models were validated using spatially stratified fivefold  
out-of-sample cross-validation. In order to offer a more stringent analysis by 
accounting for some of the spatial correlation in the data, holdout folds were 
created by combining sets of all data falling with first administrative level  
areas. Validation was performed by calculating bias (mean error), variance  
(root-mean-square error), 95% data coverage within prediction intervals and 
correlation between observed data and predictions. All validation metrics  
were calculated on the out-of-sample predictions from the fivefold cross-
validation. All validation procedures and corresponding results are provided in 
Supplementary Tables 7–18.
Projections. To compare our estimated rates of improvement in overweight  
and wasting prevalence over the last 18 years with the improvements needed 
between 2017 and 2025 to meet WHO GNTs, we performed a simple projection 
using estimated AROC applied to the final year of our estimates. Both AROC  
and projections were calculated at the draw-level to obtain the uncertainty of  
the estimates.
For each indicator i, we calculated AROC at each grid cell (m) by calculating 
the AROC between each pair of adjacent years t:
AROCu;m;t ¼ logit pu;m;tpu;m;t�1
 
We then calculated a weighted AROC for each indicator by taking a weighted 
average across the years, where more recent AROCs were given more weight in the 
average. We defined the weights to be:
Wt ¼ ðt � 2000þ 1γÞ;
where γ may be chosen to give varying amounts of weight across the years. For each 
indicator, we then calculated the average AROC to be:
AROCu;m ¼
X2017
2001
Wt ´AROCu;m;t
 !
Finally, we calculated the projections (Proj) by applying the AROC in  
our 2017 mean prevalence estimates to produce estimates in 8 years from 2017  
to 2025.
Proju;m;2025 ¼ logit�1 logit pu;m;2017
 þ AROCu;m ´ 8 :
This projection scheme is analogous to the methods used in the Global Burden 
of Disease 2017 study47 for measurement of progress and projected attainment 
of health-related Sustainable Development Goals. Our projections are based on 
the assumption that areas will sustain the current AROC, and the precision of 
the AROC estimates is dependent on the level of uncertainty emanating from the 
estimation of annual prevalence.
Priors. The following priors were used for our overweight and wasting models:
β0  N μ ¼ 0; σ2 ¼ 32ð Þ;
β iid N μ ¼ 1no: ensemblemodels ; σ2 ¼ 32
 
;
log 1þρ1�ρ
 
 Nðμ ¼ 4; σ2 ¼ 1:22Þ;
log 1σ2nug
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
log 1σ2country
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
θ1 ¼ log σ2k
   Nðμθ1 ; σ2θ1 Þ
θ2 ¼ log κð Þ  Nðμθ2; σ2θ2 Þ
Given that our covariates used in INLA (the predicted outputs from the 
ensemble models) should be on the same scale as our predictive target, we 
believe that the intercept in our model should be close to zero and that the 
regression coefficients should sum to 1. As such, we chose the prior for our 
intercept to be N(0,σ2 = 32) and the prior for the fixed-effect coefficients to be 
N 1no: ensemblemodels ; σ
2 ¼ 32 
I
. The prior on the temporal correlation parameter, 
ρ, was chosen to be mean zero, showing no prior preference for either positive or 
negative autocorrelation structure and with a distribution wide enough such that 
within three s.d. of the mean, the prior includes values of ρ ranging from −0.95 
to 0.95. The priors on the random effect variances were chosen to be relatively 
loose given that we believe our fixed-effects covariates should be well correlated 
with our outcome of interest, which might suggest relatively small random effects 
values. At the same time, we wanted to avoid using a prior that was so diffuse as 
to actually put high prior weight on large random effect variances. For stability, 
we used the uncorrelated multivariate normal priors that INLA automatically 
determines (based on the finite elements mesh) for the log-transformed spatial 
hyperparameters κ and τ. In our parameterization, we represent α and γ in the log 
gamma distribution as shape and inverse-scale, respectively.
Prior sensitivity analysis. Sensitivity analysis was undertaken to assess the impact 
of the hyper-priors for the nugget, country random effects, and space–time 
correlation. We considered two different sets of priors related to the nugget and 
country random effects and three set related to space–time correlation, resulting in 
six different combinations of hyper-priors as outlined below.
Model 1: In this model, we used the default hyper-priors in INLA75 (for both 
nugget and country random effects. The hyper-prior for the AR1 rho, ρ, was 
retained as shown below.
log 1σ2nugget
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þand
log 1σ2counry
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
log 1þρ1�ρ
 
 Normal ðμ ¼ 4; σ2 ¼ 1:22Þ
Model 2: The hyper-priors for nugget were changed as indicated below, where 
hyper-priors for country random effect were the default hyper-priors in INLA. The 
hyper-priors for the AR1 rho, ρ, were retained the same as model 1.
log 1σ2nugget
 
 loggamma α ¼ 1; γ ¼ 2ð Þ and
log 1σ2counry
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
log 1þρ1�ρ
 
 Normal ðμ ¼ 4; σ2 ¼ 1:22Þ
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Model 3: In this model the hyper-priors for country random effects and nugget 
were exchanged, where hyper-priors for nugget were the default hyper-priors in 
INLA. The hyper-priors for the AR1 rho, ρ, were retained the same as model 1.
log 1σ2nug
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ and
log 1σ2counry
 
 loggamma α ¼ 1; γ ¼ 2ð Þ:
log 1þρ1�ρ
 
 Normal ðμ ¼ 4; σ2 ¼ 1:22Þ
Model 4: In this model, we used the default hyper-priors in INLA for less 
informative nugget and country random effects. The hyper-priors for the AR1 rho, 
ρ, were changed.
log 1σ2nugget
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ and
log 1σ2counry
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
log 1þρ1�ρ
 
 Normal ðμ ¼ 0; σ2 ¼ 1:22Þ
Model 5: In this model, we used the default hyper-priors in INLA for both 
nugget and country random effects. The hyper-priors for the AR1 rho, ρ, were the 
default in INLA.
log 1σ2nugget
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ and
log 1σ2counry
 
 loggamma α ¼ 1; γ ¼ 5 ´ 10�5ð Þ:
log 1þρ1�ρ
 
 Normal ðμ ¼ 0; σ2 ¼ 2:582Þ
The predicted estimates for all models with different sets of hyper-priors were 
highly correlated at the grid-cell level and yielded low mean absolute differences 
(Supplementary Table 7). We ultimately selected the less informative priors for 
nugget and country random effects as they are default priors in the INLA package 
and have been applied widely76,77 and selected a more stringent parameterization of 
our space–time correlation, as indicated in model 1.
Mesh construction. We constructed the finite elements mesh for the stochastic 
partial differential equation approximation to the Gaussian process regression 
using a simplified polygon boundary (in which coastlines and complex boundaries 
were smoothed) for each of the regions within our model. We set the inner mesh 
triangle maximum edge length (the mesh size for areas over land) to be 0.75 
degrees and the buffer maximum edge length (the mesh size for areas over the 
ocean) to be 5 degrees. An example finite elements mesh constructed for Eastern 
SSA mesh is described by Kinyoki et al.21.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
Our study follows the Guidelines for Accurate and Transparent Health Estimates 
Reporting48 (Supplementary Table 1). The findings of this study are supported by 
data available in public online repositories, data publicly available upon request 
of the data provider and data not publicly available due to restrictions by the 
data provider. Nonpublicly available data were used under license for the current 
study but may be available from the authors upon reasonable request and with 
permission of the data provider. Details of data sources and availability can be 
found in Supplementary Tables 2–5. The full output of the analyses are publicly 
available in the Global Health Data Exchange (http://ghdx.healthdata.org/record/
ihme-data/lmic-double-burden-of-malnutrition-geospatial-estimates-2000-2017) 
and can further be explored via customized data visualization tools (https://vizhub.
healthdata.org/lbd/dbm.). Administrative boundaries were retrieved from the 
Database of Global Administrative Areas39. Land cover was retrieved from the 
online Data Pool, courtesy of the NASA EOSDIS Land Processes Distributed  
Active Archive Center, USGS/Earth Resources Observation and Science Center, 
Sioux Falls, South Dakota40. Lakes were retrieved from the Global Lakes and 
Wetlands Database, courtesy of the World Wildlife Fund and the Center for 
Environmental Systems Research, University of Kassel41,42. Populations were 
retrieved from WorldPop43,44.
Code availability
All code used for these analyses is publicly available online at http://ghdx.
healthdata.org/record/ihme-data/lmic-double-burden-of-malnutrition-geospatial-
estimates-2000-2017 and at http://github.com/ihmeuw/lbd/tree/dbm-lmic-2020.
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Extended Data Fig. 1 | Prevalence of under-5 childhood overweight in LMiCs in 2017 at administrative levels 0, 1, 2, and at 5 × 5-km resolution. 
Prevalence of overweight among children under 5 at administrative level 0 (national-level estimates) (a), first administrative unit (b), second 
administrative unit (c), and at the 5 × 5-km resolution (d). Maps reflect administrative boundaries, land cover, lakes, and population; grey-coloured grid 
cells were classified as “barren or sparsely vegetated” and had fewer than ten people per 1 × 1-km grid cell39–45, or were not included in this analysis. Maps 
were generated using ArcGIS Desktop 10.6.
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Extended Data Fig. 2 | Prevalence of under-5 child wasting in LMiCs at administrative levels 0, 1, 2, and at 5 × 5-km resolution in 2017. Prevalence of 
wasting among children under 5 at administrative level 0 (national-level estimates) (a), first administrative unit (b), second administrative unit (c), and at 
the 5 × 5-km resolution (d). Maps reflect administrative boundaries, land cover, lakes, and population; grey-coloured grid cells were classified as “barren 
or sparsely vegetated” and had fewer than ten people per 1 × 1-km grid cell39–45, or were not included in this analysis. Maps were generated using ArcGIS 
Desktop 10.6.
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Extended Data Fig. 3 | Modelling regions. Modelling regions46 were based on geographic and socio-demographic index (SDI) regions from the Global 
Burden of Disease47, defined as: Andean South America, Central America and the Caribbean, Central sub-Saharan Africa (SSA), East Asia, Eastern SSA, 
Middle East, North Africa, Oceania, Southeast Asia, South Asia, South SSA, Central Asia, Tropical South America, and Western SSA. Regions in grey (Stage 
3) were not included in our models due to high-middle and high SDI. Map was generated using ArcGIS Desktop 10.6.
 46. Murray, C. J. et al. GBD 2010: design, definitions and metrics. Lancet 380, 2063–2066 (2012).
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Data collection No primary data collection was carried out for this analysis
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size was calculated as the number of unique data source-location pairs with observations of overweight and wasting prevalence. This 
sample size is reported in the main text under Global and location variation in malnutrition trends,"...using data from 420 household surveys 
representing more than 3 million children, we map the relative burdens of overweight and wasting among under-5 children in 105 LMICs from 
2000 to 2017."
Data exclusions     
Replication This is an observational study using many years of survey and surveillance data and could be replicated.
Randomization This analysis is an observational mapping study and there were no experimental groups.
Blinding Blinding was not relevant to this study, as it was an observational study using survey and surveillance data.
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Reasons for data exclusion were pre-established and are described in supplementary table 5. For a survey to be considered for this analysis, we 
required information on height, weight, age and sex. Select data sources were excluded from the analysis due to: missing survey weights, missing 
sex and age variable, incomplete sampling (e.g., only a specific age range), or untrustworthy data (as determined by the survey administrator or by 
inspection). 
